SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Varsha Honmore, Amit Kandhare, Anand A. Zanwar, Supada Rojatkar, Subhash Bodhankar, Arun Natu, Artemisia pallensalleviates acetaminophen induced toxicity via modulation of endogenous biomarkers, Pharmaceutical Biology, 2014, 1

    CrossRef

  2. 2
    Sung Gyu Im, Sun Hong Yoo, Dong Ok Jeon, Hyo Jin Cho, Jin Young Choi, Soya Paik, Young Min Park, Chelidonium majus-Induced Acute Hepatitis, The Ewha Medical Journal, 2014, 37, 1, 60

    CrossRef

  3. 3
    Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli, Factors affecting drug-induced liver injury: antithyroid drugs as instances, Clinical and Molecular Hepatology, 2014, 20, 3, 237

    CrossRef

  4. 4
    François Montastruc, Stefania Scotto, Ines Ribeiro Vaz, Leonor Nogueira Guerra, Antonio Escudero, María Sáinz, Teresa Falomir, Haleh Bagheri, Maria Teresa Herdeiro, Mauro Venegoni, Jean Louis Montastruc, Alfonso Carvajal, Hepatotoxicity Related to Agomelatine and Other New Antidepressants, Journal of Clinical Psychopharmacology, 2014, 34, 3, 327

    CrossRef

  5. 5
    S Hyder Hussaini, Elizabeth Anne Farrington, Idiosyncratic drug-induced liver injury: an update on the 2007 overview, Expert Opinion on Drug Safety, 2014, 13, 1, 67

    CrossRef

  6. You have free access to this content6
    H. Karl Greenblatt, David J. Greenblatt, Liver injury associated with ketoconazole: Review of the published evidence, The Journal of Clinical Pharmacology, 2014, 54, 12
  7. 7
    Grace Lai-Hung Wong, Yuk-Him Tam, Chi-Fai Ng, Anthony Wing-Hung Chan, Paul Cheung-Lung Choi, Winnie Chiu-Wing Chu, Paul Bo-San Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Liver Injury Is Common Among Chronic Abusers of Ketamine, Clinical Gastroenterology and Hepatology, 2014, 12, 10, 1759

    CrossRef

  8. You have free access to this content8
    Jose Serrano, LiverTox: An online information resource and a site for case report submission on drug-induced liver injury, Clinical Liver Disease, 2014, 4, 1
  9. 9
    Robert J. Fontana, Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914

    CrossRef

  10. 10
    Ilrang Kim, Secretion of Inflammatory Cytokines by Aloe vera Extract in HepG2 Cells, The Korean Journal of Food And Nutrition, 2014, 27, 3, 400

    CrossRef

  11. 11
    Thomas J. Urban, Hans Tillmann, Handbook of Pharmacogenomics and Stratified Medicine, 2014,

    CrossRef

  12. 12
    Steven P. Stanos, Mark D. Tyburski, Sagar S. Parikh, Practical Management of Pain, 2014,

    CrossRef

  13. 13
    Omar I. Saadah, Rana Y. Bokhary, Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl, Arab Journal of Gastroenterology, 2013, 14, 3, 130

    CrossRef

  14. 14
    Christin M. Giordano, Xaralambos B. Zervos, Clinical Manifestations and Treatment of Drug-induced Hepatotoxicity, Clinics in Liver Disease, 2013, 17, 4, 565

    CrossRef

  15. 15
    Anna Mrzljak, Iva Kosuta, Anita Skrtic, Tajana Filipec Kanizaj, Radovan Vrhovac, Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital, Case Reports in Gastroenterology, 2013, 7, 1, 19

    CrossRef

  16. 16
    James H. Lewis, Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist, Pharmaceutical Medicine, 2013, 27, 3, 165

    CrossRef

  17. 17
    Vincent Lo Re, Kevin Haynes, David Goldberg, Kimberly A. Forde, Dena M. Carbonari, Kimberly B. F. Leidl, Sean Hennessy, K. Rajender Reddy, Pamala A. Pawloski, Gregory W. Daniel, T. Craig Cheetham, Aarthi Iyer, Kara O. Coughlin, Sengwee Toh, Denise M. Boudreau, Nandini Selvam, William O. Cooper, Mano S. Selvan, Jeffrey J. VanWormer, Mark I. Avigan, Monika Houstoun, Gwen L. Zornberg, Judith A. Racoosin, Azadeh Shoaibi, Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini-Sentinel Distributed Database, Pharmacoepidemiology and Drug Safety, 2013, 22, 8
  18. 18
    Paul B. Watkins, Drug-induced Liver Disease, 2013,

    CrossRef

  19. 19
    Mark I. Avigan, Drug-induced Liver Disease, 2013,

    CrossRef

  20. 20
    Ki Tae Suk, Dong Joon Kim, Chang Hoon Kim, Seung Ha Park, Jai Hoon Yoon, Yeon Soo Kim, Gwang Ho Baik, Jin Bong Kim, Young Oh Kweon, Byung Ik Kim, Seok Hyun Kim, In Hee Kim, Ju Hyun Kim, Soon Woo Nam, Yong Han Paik, Jeong Ill Suh, Joo Hyun Sohn, Byung Min Ahn, Soon Ho Um, Heon Ju Lee, Mong Cho, Myoung Kuk Jang, Sung Kyu Choi, Seong Gyu Hwang, Ho Taik Sung, Jong Young Choi, Kwang Hyub Han, A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea, The American Journal of Gastroenterology, 2012, 107, 9, 1380

    CrossRef

  21. 21
    Timothy J. Davern, Drug-Induced Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 231

    CrossRef

  22. 22
    David Sprague, Kiran Bambha, Drug-induced liver injury due to varenicline: a case report, BMC Gastroenterology, 2012, 12, 1, 65

    CrossRef

  23. 23
    Ki Tae Suk, Dong Joon Kim, Drug-induced liver injury: present and future, Clinical and Molecular Hepatology, 2012, 18, 3, 249

    CrossRef

  24. 24
    BP Fairfax, S Pratap, ISD Roberts, J Collier, R Kaplan, AM Meade, AW Ritchie, T Eisen, VM Macaulay, A Protheroe, Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma, BMC Cancer, 2012, 12, 1, 590

    CrossRef

  25. 25
    Stepan Sembera, Craig Lammert, Jayant A. Talwalkar, Schuyler O. Sanderson, John J. Poterucha, J. Eileen Hay, Russell H. Wiesner, Gregory J. Gores, Charles B. Rosen, Julie K. Heimbach, Michael R. Charlton, Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation, Liver Transplantation, 2012, 18, 7
  26. 26
    L. N. Bell, R. Vuppalanchi, P. B. Watkins, H. L. Bonkovsky, J. Serrano, R. J. Fontana, M. Wang, J. Rochon, N. Chalasani, Serum proteomic profiling in patients with drug-induced liver injury, Alimentary Pharmacology & Therapeutics, 2012, 35, 5
  27. 27
    Hye Young Ju, Jae Young Jang, Soung Won Jeong, Sung Ae Woo, Min Gyu Kong, Hee Yoon Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, So Young Jin, Hong Soo Kim, Boo Sung Kim, The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis, Clinical and Molecular Hepatology, 2012, 18, 2, 213

    CrossRef

  28. 28
    M.-C. Zanella, L. Rubbia-Brandt, E. Giostra, Y. Chalandon, A. Hadengue, L. Spahr, A Case of Drug-Induced Hepatitis due to Lenalidomide, Case Reports in Gastroenterology, 2011, 5, 1, 217

    CrossRef

  29. 29
    Timothy J. Davern, Naga Chalasani, Robert J. Fontana, Paul H. Hayashi, Petr Protiva, David E. Kleiner, Ronald E. Engle, Hanh Nguyen, Suzanne U. Emerson, Robert H. Purcell, Hans L. Tillmann, Jiezhun Gu, Jose Serrano, Jay H. Hoofnagle, Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury, Gastroenterology, 2011, 141, 5, 1665

    CrossRef

  30. 30
    Joanne L. Thanavaro, An Overview of Drug-induced Liver Injury, The Journal for Nurse Practitioners, 2011, 7, 10, 819

    CrossRef

  31. 31
    Qing Zhang, Zhijian Yang, Can statins be used safely in coronary heart disease patients of Hepatitis B virus carriers?, International Journal of Cardiology, 2011, 146, 2, 291

    CrossRef

  32. 32
    Jean P. Molleston, Robert J. Fontana, M. James Lopez, David E. Kleiner, Jiezhun Gu, Naga Chalasani, Characteristics of Idiosyncratic Drug-induced Liver Injury in Children, Journal of Pediatric Gastroenterology and Nutrition, 2011, 53, 2, 182

    CrossRef

  33. 33
    Eric S. Orman, Hari S. Conjeevaram, Raj Vuppalanchi, James W. Freston, James Rochon, David E. Kleiner, Paul H. Hayashi, Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury, Clinical Gastroenterology and Hepatology, 2011, 9, 6, 517

    CrossRef

  34. 34
    Albert J. Czaja, Drug-Induced Autoimmune-Like Hepatitis, Digestive Diseases and Sciences, 2011, 56, 4, 958

    CrossRef

  35. 35
    Alexandra Heurgué-Berlot, Brigitte Bernard-Chabert, Marie-Danièle Diebold, Gérard Thiéfin, Drug-Induced Autoimmune-Like Hepatitis: A Case of Chronic Course After Drug Withdrawal, Digestive Diseases and Sciences, 2011, 56, 8, 2504

    CrossRef

  36. 36
    Shannan Tujios, Robert J. Fontana, Mechanisms of drug-induced liver injury: from bedside to bench, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 4, 202

    CrossRef

  37. 37
    David Groen, Stephen Harris, Salvatore Colucci, Glen Apseloff, Serum Transaminase Levels Should Be Measured Immediately Prior to Dosing in Early Phase I Clinical Trials, The Journal of Clinical Pharmacology, 2011, 51, 2
  38. 38
    David E. Kleiner, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  39. 39
    Paul B Watkins, Biomarkers for drug-induced liver injury, Therapy, 2010, 7, 4, 367

    CrossRef

  40. 40
    Don C. Rockey, Leonard B. Seeff, James Rochon, James Freston, Naga Chalasani, Maurizio Bonacini, Robert J. Fontana, Paul H. Hayashi, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method, Hepatology, 2010, 51, 6
  41. 41
    J. M. Leitner, W. Graninger, F. Thalhammer, Hepatotoxicity of Antibacterials: Pathomechanisms and Clinical Data, Infection, 2010, 38, 1, 3

    CrossRef

  42. 42
    Jeffrey B. Schwimmer, Winston Dunn, Gregory J. Norman, Perrie E. Pardee, Michael S. Middleton, Nanda Kerkar, Claude B. Sirlin, SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease, Gastroenterology, 2010, 138, 4, 1357

    CrossRef

  43. 43
    Harshad Devarbhavi, Ross Dierkhising, Walter K Kremers, M S Sandeep, Dheeraj Karanth, C K Adarsh, Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality, The American Journal of Gastroenterology, 2010, 105, 11, 2396

    CrossRef

  44. 44
    Robert J. Fontana, Leonard B. Seeff, Raúl J. Andrade, Einar Björnsson, Christopher P. Day, Jose Serrano, Jay H. Hoofnagle, Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop, Hepatology, 2010, 52, 2
  45. 45
    Ramazan Idilman, Mehmet Bektas, Kubilay Cnar, Murat Toruner, Ethem Turgay Cerit, Beyza Doganay, Esra Erden, Hakan Bozkaya, Kadir Bahar, Selim Karayalcin, Irfan Soykan, Murat Palabiyikoglu, Hulya Cetinkaya, Cihan Yurdaydin, Abdulkadir Dokmeci, Ali Ozden, The Characteristics and Clinical Outcome of Drug-induced Liver Injury, Journal of Clinical Gastroenterology, 2010, 44, 6, e128

    CrossRef

  46. You have free access to this content46
    S. TREEPRASERTSUK, J. HUNTRAKUL, W. RIDTITID, P. KULLAVANIJAYA, E. S. BJÖRNSSON, The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents, Alimentary Pharmacology & Therapeutics, 2010, 31, 11
  47. 47
    Robert J. Fontana, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  48. 48
    Alexandre Mottu, Laura Rubbia-Brandt, Florian Bihl, Antoine Hadengue, Laurent Spahr, Acute hepatitis due to brivudin: A case report, Journal of Hepatology, 2009, 51, 5, 967

    CrossRef

  49. 49
    Jun-Won Yun, Chae-Wook Kim, Il-Hong Bae, Young-Ho Park, Jin-Ho Chung, Kyung-Min Lim, Kyung-Sun Kang, Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure, Toxicology and Applied Pharmacology, 2009, 239, 1, 55

    CrossRef

  50. 50
    Robert J. Fontana, Paul B. Watkins, Herbert L. Bonkovsky, Naga Chalasani, Timothy Davern, Jose Serrano, James Rochon, Drug-Induced Liver Injury Network (DILIN) Prospective Study, Drug Safety, 2009, 32, 1, 55

    CrossRef

  51. 51
    M. Kebieche, Z. Lakroun, M. Lahouel, J. Bouayed, Z. Meraihi, R. Soulimani, Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration, Experimental and Toxicologic Pathology, 2009, 61, 2, 161

    CrossRef

  52. 52
    Christine M. Hunt, John K. Forster, Julie I. Papay, Heide A. Stirnadel, Evidence-Based Liver Chemistry Monitoring in Drug Development, Pharmaceutical Medicine, 2009, 23, 3, 149

    CrossRef

  53. 53
    M. Tamzaourte, I. Errabih, H. Krami, L. Ouazzani, N. Benzzoubeir, M. Fadlouallah, M. Lahmiri, G. Kharrasse, S. Tahri, H. Elkoundi, H. Ouazzani, Hépatite aiguë cytolytique induite par l’allopurinol chez un patient traité pour hépatite virale C, Journal Africain d'Hépato-Gastroentérologie, 2009, 3, 3, 160

    CrossRef

  54. 54
    David N Assis, Victor J Navarro, Human drug hepatotoxicity: a contemporary clinical perspective, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 5, 463

    CrossRef

  55. 55
    M. Isabel Lucena, Raúl J. Andrade, Neil Kaplowitz, Miren García-Cortes, M. Carmen Fernández, Manuel Romero-Gomez, Miguel Bruguera, Hacibe Hallal, Mercedes Robles-Diaz, Jose F. Rodriguez-González, Jose Maria Navarro, Javier Salmeron, Pedro Martinez-Odriozola, Ramón Pérez-Alvarez, Yolanda Borraz, Ramón Hidalgo, Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex, Hepatology, 2009, 49, 6
  56. 56
    Rolf Teschke, Alexander Schwarzenboeck, Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): Critical analysis and structured causality assessment, Phytomedicine, 2009, 16, 1, 72

    CrossRef

  57. 57
    Allen D. Brinker, Ronald T. Wassel, Jenna Lyndly, Jose Serrano, Mark Avigan, William M. Lee, Leonard B. Seeff, Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases, Hepatology, 2009, 49, 1
  58. 58
    Shashi K. Ramaiah, Atrayee Banerjee, Handbook of Toxicology of Chemical Warfare Agents, 2009,

    CrossRef

  59. 59
    PAULETTE BIOULAC-SAGE, CHARLES BALABAUD, Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, 2009,

    CrossRef

  60. 60
    Charles Her, Acetaminophen-induced, Not Desflurane-induced, Hepatotoxicity, Anesthesiology, 2008, 109, 3, 570

    CrossRef

  61. 61
    Robert J. Fontana, Acute Liver Failure Including Acetaminophen Overdose, Medical Clinics of North America, 2008, 92, 4, 761

    CrossRef

  62. 62
    William M. Lee, Robert H. Squires, Scott L. Nyberg, Edward Doo, Jay H. Hoofnagle, Acute liver failure: Summary of a workshop, Hepatology, 2008, 47, 4
  63. 63
    Ketevan Pachkoria, M. Isabel Lucena, Esperanza Crespo, Francisco Ruiz-Cabello, Susana Lopez-Ortega, Ma. Carmen Fernandez, Manuel Romero-Gomez, Ana Madrazo, Jose Antonio Durán, Ana Malcon de Dios, Yolanda Borraz, Jose Maria Navarro, Raúl J. Andrade, Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome, Journal of Hepatology, 2008, 49, 1, 107

    CrossRef

  64. 64
    Ma Isabel Lucena, Miren García-Cortés, Raquel Cueto, JL Lopez-Duran, Raúl J Andrade, Assessment of drug-induced liver injury in clinical practice, Fundamental & Clinical Pharmacology, 2008, 22, 2
  65. 65
    Rolf Teschke, Alexander Schwarzenboeck, Karl-Heinz Hennermann, Causality assessment in hepatotoxicity by drugs and dietary supplements, British Journal of Clinical Pharmacology, 2008, 66, 6
  66. 66
    Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States, Gastroenterology, 2008, 135, 6, 1924

    CrossRef

  67. 67
    Fabio Macchi, Comments on assessment of drug-induced liver injury in clinical practice by Lucena MI et al., Fundamental & Clinical Pharmacology 2008; 22: 141–158, Fundamental & Clinical Pharmacology, 2008, 22, 6
  68. 68
    Alfred Ammoury, Fouad El Sayed, Caroline Farah, Jacques Bazex, Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma, Journal of the American Academy of Dermatology, 2008, 58, 3, 532

    CrossRef

  69. 69
    M. Isabel Lucena, Raúl J. Andrade, Carmen Martínez, Eugenia Ulzurrun, Elena García-Martín, Yolanda Borraz, M. Carmen Fernández, Manuel Romero-Gomez, Agustin Castiella, Ramón Planas, Joan Costa, Sandra Anzola, José A. G. Agúndez, Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury, Hepatology, 2008, 48, 2
  70. 70
    Rolf Teschke, Alexander Schwarzenboeck, Karl-Heinz Hennermann, Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases, European Journal of Gastroenterology & Hepatology, 2008, 20, 12, 1182

    CrossRef

  71. 71
    Shuji Goto, Takayuki Seo, Takashi Hagiwara, Kentaro Ueda, Tsuyuko Yamauchi, Shiro Nagata, Yukio Ando, Takateru Ishitsu, Kazuko Nakagawa, Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients, Journal of Pharmacy and Pharmacology, 2008, 60, 2
  72. 72
    Craig Lammert, Stefan Einarsson, Chandan Saha, Anna Niklasson, Einar Bjornsson, Naga Chalasani, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals, Hepatology, 2008, 47, 6
  73. 73
    James Rochon, Petr Protiva, Leonard B. Seeff, Robert J. Fontana, Suthat Liangpunsakul, Paul B. Watkins, Timothy Davern, John G. McHutchison, Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury, Hepatology, 2008, 48, 4
  74. 74
    M. F. B. Silva, C. C. P. Aires, P. B. M. Luis, J. P. N. Ruiter, L. IJlst, M. Duran, R. J. A. Wanders, I. Tavares de Almeida, Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review, Journal of Inherited Metabolic Disease, 2008, 31, 2, 205

    CrossRef

  75. 75
    John R. Senior, What is idiosyncratic hepatotoxicity? What is it not?, Hepatology, 2008, 47, 6
  76. 76
    Steven P. Stanos, Mark D. Tyburski, Raj's Practical Management of Pain, 2008,

    CrossRef

  77. 77
    Anne M. Larson, Acetaminophen Hepatotoxicity, Clinics in Liver Disease, 2007, 11, 3, 525

    CrossRef

  78. 78
    Max A. Shapiro, James H. Lewis, Causality Assessment of Drug-Induced Hepatotoxicity: Promises and Pitfalls, Clinics in Liver Disease, 2007, 11, 3, 477

    CrossRef

  79. 79
    Cherinne Arundel, James H Lewis, Drug-induced liver disease in 2006, Current Opinion in Gastroenterology, 2007, 23, 3, 244

    CrossRef

  80. 80
    Gebran Abboud, Neil Kaplowitz, Drug-Induced Liver Injury, Drug Safety, 2007, 30, 4, 277

    CrossRef

  81. 81
    Alison M. Brind, Drugs that damage the liver, Medicine, 2007, 35, 1, 26

    CrossRef

  82. 82
    K Pachkoria, M I Lucena, F Ruiz-Cabello, E Crespo, M R Cabello, R J Andrade, Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI), British Journal of Pharmacology, 2007, 150, 6
  83. 83
    Yi-Shin Huang, Wei-Juin Su, Yi-Hsiang Huang, Chih-Yen Chen, Full-Young Chang, Han-Chieh Lin, Shou-Dong Lee, Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury, Journal of Hepatology, 2007, 47, 1, 128

    CrossRef

  84. 84
    Kentaro Ueda, Takateru Ishitsu, Takayuki Seo, Nao Ueda, Tsukasa Murata, Masaharu Hori, Kazuko Nakagawa, GlutathioneS-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity, Pharmacogenomics, 2007, 8, 5, 435

    CrossRef

  85. 85
    Jay H Lefkowitch, Hepatobiliary pathology, Current Opinion in Gastroenterology, 2007, 23, 3, 221

    CrossRef

  86. 86
    S Hyder Hussaini, Elizabeth A Farrington, Idiosyncratic drug-induced liver injury: an overview, Expert Opinion on Drug Safety, 2007, 6, 6, 673

    CrossRef

  87. 87
    G Ghibellini, L S Vasist, E M Leslie, W D Heizer, R J Kowalsky, B F Calvo, K L R Brouwer, In Vitro–In Vivo Correlation of Hepatobiliary Drug Clearance in Humans, Clinical Pharmacology & Therapeutics, 2007, 81, 3, 406

    CrossRef

  88. 88
    Urs A. Boelsterli, Priscilla L.K. Lim, Mitochondrial abnormalities—A link to idiosyncratic drug hepatotoxicity?, Toxicology and Applied Pharmacology, 2007, 220, 1, 92

    CrossRef

  89. 89
    Adrian Reuben, Needles in Haystacks, The American Journal of Gastroenterology, 2007, 102, 11, 2444

    CrossRef

  90. 90
    C. Y. CHANG, T. D. SCHIANO, Review article: drug hepatotoxicity, Alimentary Pharmacology & Therapeutics, 2007, 25, 10
  91. 91
    Kartik Jinjuvadia, Wendy Kwan, Robert J. Fontana, Searching for a Needle in a Haystack: Use of ICD-9-CM Codes in Drug-Induced Liver Injury, The American Journal of Gastroenterology, 2007, 102, 11, 2437

    CrossRef

  92. 92
    C. Warren Olanow, Paul B. Watkins, Tolcapone, Clinical Neuropharmacology, 2007, 30, 5, 287

    CrossRef

  93. 93
    Paula B.M. Luís, Jos P.N. Ruiter, Cátia C.P. Aires, Graça Soveral, Isabel Tavares de Almeida, Marinus Duran, Ronald J.A. Wanders, Margarida F.B. Silva, Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation, Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2007, 1767, 9, 1126

    CrossRef

  94. 94
    Kathleen M. Giacomini, Ronald M. Krauss, Dan M. Roden, Michel Eichelbaum, Michael R. Hayden, Yusuke Nakamura, When good drugs go bad, Nature, 2007, 446, 7139, 975

    CrossRef

  95. 95
    Karyn Bischoff, Shashi K. Ramaiah, Veterinary Toxicology, 2007,

    CrossRef

  96. 96
    José V Castell, Marta Castell, Allergic hepatitis induced by drugs, Current Opinion in Internal Medicine, 2006, 5, 5, 431

    CrossRef

  97. 97
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2006, 15, 9
  98. 98
    Drug-Related Hepatotoxicity, New England Journal of Medicine, 2006, 354, 20, 2191

    CrossRef

  99. 99
    Brian D. Juran, Konstantinos N. Lazaridis, Genetics of Hepatobiliary Diseases, Clinical Gastroenterology and Hepatology, 2006, 4, 5, 548

    CrossRef

  100. 100
    Y. Horsmans, Place de la biopsie hépatique en présence d’une maladie hépatique chronique chez l’adulte, Acta Endoscopica, 2006, 36, 3, 293

    CrossRef

  101. 101
    Xi Yang, William B. Mattes, Qiang Shi, Zuquan Weng, William F. Salminen, Cell-free microRNAs as Biomarkers in Human Diseases,
  102. 102
    Raúl J Andrade, M Isabel Lucena, Drug Induced Liver Disease: Mechanisms and Diagnosis,
  103. 103
    Sharon Gwaltney-Brant, Hepatobiliary System,
  104. 104
    Paul B. Watkins, Mechanisms of Drug-Induced Liver Injury,
  105. 105
    William B. Mattes, Frank D. Sistare, Qualification of Safety Biomarkers for Application to Early Drug Development, Pharmaceutical Sciences Encyclopedia,
  106. 106
    Josef S. Ozer, William J. Reagan, Shelli Schomaker, Joe Palandra, Mike Baratta, Shashi Ramaiah, Translational Biomarkers of Acute Drug-Induced Liver Injury: The Current State, Gaps, and Future Opportunities,